Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Acyltransferase
    (1)
  • Akt
    (1)
  • IL Receptor
    (1)
  • LPL Receptor
    (1)
  • NF-κB
    (1)
  • PI3K
    (1)
  • S1P Receptor
    (1)
  • STAT
    (1)
  • p38 MAPK
    (1)
Filter
Search Result
Results for "

ischaemia-reperfusion injury

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
SEW​2871
SEW2871
T2171256414-75-2
SEW 2871 is an orally available, highly selective S1P1 agonist with an EC50 of 13.8 nM.It reduces the number of lymphocytes in the blood and is used in studies related to diabetes, Alzheimer's disease, liver fibrosis, and inflammation. It activates ERK, Akt and Rac signaling pathways and induces S1P1 internalization and recycling.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Hot
VULM 1457
T23521228544-65-8
VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ac2-26
TP1373151988-33-9
Ac2-26, an annexin A1 mimetic peptide, was able to attenuate renal inflammatory injury in a diabetic mouse model through inhibition of p38MAPK/NF-κB, as well as sepsis-induced cardiomyocyte apoptosis through the LXA4/PI3K/AKT signalling pathway, and hepatic ischaemia-reperfusion injury in mice by modulating IL-22/IL-22R1/STAT3 signalling pathway.
  • $52
In Stock
Size
QTY